INFORMATION AND RESOURCES FOR U.S. HEALTHCARE PROFESSIONALS FROM SPLENDA BRAND SWEETENER (SUCRALOSE)

Diabetes Management

The numbers are staggering.

  • Over 20 million children and adults in the United States have diabetes1
  • 54 million Americans have prediabetes1
  • The total economic cost of diabetes in 2007 was estimated at $174 billion2

Clearly, something needs to be done.

Making a number of small lifestyle changes can have a big impact—especially if they‘re changes patients can make and stick with. A variety of measures can be recommended to improve the diet and increase physical activity for better health.

One small change is replacing sugar with SPLENDA® Brand Sweetener (sucralose). It offers patients with diabetes reduced sugar, calorie, and carbohydrate intake—without reduced taste.

Clinical studies confirm sucralose does not affect blood glucose levels.

Randomized, double-blind, placebo-controlled, crossover study demonstrates that sucralose does not adversely affect short-term blood glucose control in patients with type 1 or type 2 diabetes.3

View study abstract now

Results of a multicenter study demonstrated that daily sucralose consumption of triple the maximum projected daily intake for 3 months had no effect on glucose homeostasis in patients with type 2 diabetes.4

View study abstract now

SPLENDA® Brand Sweetener (sucralose) can be used safely by all populations, including people with diabetes, women who are pregnant or nursing, and children.

Sucralose: A Scientific and Safety Review

In addition to sucralose, SPLENDA® No Calorie Sweetener Products contain small amounts of food ingredients commonly found in other no-calorie sweeteners, which are added for texture and volume. SPLENDA® Packets contain the carbohydrates maltodextrin and dextrose; SPLENDA® Granulated Sweetener contains just maltodextrin. Up to 4 packets of SPLENDA® No Calorie Sweetener or 8 teaspoons of granulated is considered a “free food“ for people with diabetes.

References

1. All about diabetes. American Diabetes Association Web site. http://www.diabetes.org/about-diabetes.jsp. Accessed April 25, 2008.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007: executive summary. http://www.diabetes.org/uedocuments/cost-diabetes-executive-summary.pdf. Accessed April 28, 2008.
3. Mezitis NHE, Maggio CA, Koch P, et al. Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes. Diabetes Care. 1996;19(9):1004-1005.
4. Grotz VL, Henry RR, McGill JB, et al. Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc. 2003;103(12):1607-1612.

New SplENDA® Resource Center

Get samples and patient materials delivered directly to your office.

Register Now

Log In






Questions or Comments? Call the toll-free SPLENDA® Healthcare Professional line at
1-866-948-6883 or go to Customer Service.

Privacy Policy | Legal Notice

© McNeil Nutritionals, LLC, 2009 | Ft. Washington PA, USA | All rights reserved.
This site is published by McNeil Nutritionals, LLC, which is solely responsible for its contents.
This site and its contents are intended for U.S. healthcare professionals only.